Non-response to daclatasvir and asunaprevir therapy in patients co-infected with hepatitis C virus genotypes 1 and 2-Reference-Cited by-同舟云学术

Non-response to daclatasvir and asunaprevir therapy in patients co-infected with hepatitis C virus genotypes 1 and 2

Published:2016-08-26 Issue:4 Volume:47 Page:364-367
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Sohda Tetsuro¹,Yamauchi Eri¹,Anan Akira¹,Yokoyama Keiji¹,Fukunaga Atsushi¹,Yamauchi Ryo¹,Fukuda Sho¹,Takata Kazuhide¹,Tanaka Takashi¹,Hanano Takayuki¹,Kitamura Yuji¹,Morihara Daisuke¹,Takeyama Yasuaki¹,Irie Makoto¹,Shakado Satoshi¹,Sakisaka Shotaro¹

Affiliation:

1. Department of Gastroenterology, Faculty of Medicine; Fukuoka University; Fukuoka Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12758/fullpdf

Reference18 articles.

1. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma;Martel;Hepatology,2015

2. Epidemiology and clinical aspects on hepatitis C;Higuchi;Jpn J Infect Dis,2002

3. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan;Ikai;Hepatol Res.,2007